Seok Ju Seong

ORCID: 0000-0003-3820-3412 · 37 papers in corpus
observational 2025
Journal of clinical medicine ·doi:10.3390/jcm14165656

Objectives: The objective of this study was to evaluate the safety of postoperative in vitro fertilization (IVF) for atypical endometriosis (AE) in terms of ovarian endometrioma recurrence and development of endometriosis-related ovarian ca…

other 2025
Trials ·doi:10.1186/s13063-025-09222-w

BACKGROUND: Advanced hemostatic devices (AHDs) are widely utilized in gynecologic minimally invasive surgeries. These AHDs control ultrasonic or bipolar electric/thermal energy with a feedback mechanism and effectively seal vessels without …

other 2025
Journal of clinical medicine ·doi:10.3390/jcm14113800

Objectives: This study aimed to compare the impact of robotic (RO) versus laparoscopic single-site ovarian cystectomy (LO) on ovarian reserve, as measured by changes in anti-Müllerian hormone (AMH) levels. Methods: A total of 43 women under…

other 2024
Journal of personalized medicine ·doi:10.3390/jpm14080827

In this study, we aimed to demonstrate the feasibility and safety of navigating the ureters, middle sacral artery (MSA), and superior hypogastric nerve (SHN) using indocyanine green (ICG) and near-infrared fluorescence (NIRF) imaging during…

observational 2024
Yonsei medical journal ·doi:10.3349/ymj.2023.0099

PURPOSE: There are many studies regarding the increased relationship between pregnancy outcomes of singleton with endometriosis. However, there was limited evidence of twin pregnancies with endometriosis. This study aimed to compare the pre…

2024
·doi:10.3802/jgo.2024.35.s1.0106

Undifferentiated sarcoma is most rare inside this category, and it is difficult to be deal with if existence of both locally advanced disease and multiple end-organs metastases.No effective adjuvant therapy, including chemotherapy and radia…

other 2023
Journal of personalized medicine ·doi:10.3390/jpm13091345

This study aimed to demonstrate the feasibility of ureteral navigation using intraoperative indocyanine green (ICG) and near-infrared fluorescence (NIRF) imaging during complex laparoscopic or robot-assisted gynecologic surgery (LRAGS). Twe…

observational 2023
·doi:10.21203/rs.3.rs-2376445/v1

Abstract Background: There are many studies regarding the increased relationship between pregnancy outcomes and obstetrical complications of singleton with endometriosis such as preterm birth, preeclampsia, placenta previa, and small for ge…

observational 2023
Yonsei medical journal ·doi:10.3349/ymj.2022.0278

PURPOSE: The aims of this study were to evaluate the cumulative recurrence, reoperation, and pregnancy rates after ovarian endometrioma surgery at a single institution for more than a 5-year follow-up period. MATERIALS AND METHODS: This st…

observational 2022
Yonsei medical journal ·doi:10.3349/ymj.2022.63.5.446

PURPOSE: This study aimed to evaluate the cumulative recurrence rate and risk factors for recurrent abdominal wall endometriosis (AWE) after surgical treatment. MATERIALS AND METHODS: A retrospective cohort study was conducted at a single …

observational 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00787-w

Several clinical trials in women with endometriosis demonstrated that dienogest reduces endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL in dienogest-treated patients in real-world setting, we conduct…

2022
·doi:10.60692/z8whg-3sb76

Several clinical trials in women with endometriosis demonstrated that dienogest reduces endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL in dienogest-treated patients in real-world setting, we conduct…

2022
·doi:10.60692/gqf23-1bp94

Several clinical trials in women with endometriosis demonstrated that dienogest reduces endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL in dienogest-treated patients in real-world setting, we conduct…

other 2022
Journal of ovarian research ·doi:10.1186/s13048-022-00975-5

BACKGROUND: Ovarian "seromucinous carcinoma" has been recently removed in 2020 5th Edition of WHO classification of Female Genital Tumors and is considered as a subtype of endometrioid carcinoma with mucinous differentiation, while "seromuc…

observational 2021
Medicine ·doi:10.1097/md.0000000000026075

We aimed to determine clinical factors predicting successful pregnancy by comparing pregnancy failure and success groups after adenomyomectomy. Additionally, we analyzed fertility outcomes after adenomyomectomy.The medical records of 43 pat…

2021
·doi:10.1016/j.fertnstert.2021.07.557
observational 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.08.054

OBJECTIVES: The aims of this study were to evaluate the clinical characteristics and recurrence rate of atypical endometriosis (AE)1 compared to typical endometriosis (TE) in addition to the malignant transformation rate among a large cohor…

observational 2020
Scientific reports ·doi:10.1038/s41598-020-73434-0

The aim of this study was to evaluate the rate of and risk factors for recurrence ovarian endometrioma after conservative surgery in patients aged 40-49 years. This retrospective, single-center study included 408 women between January 2008 …

observational 2019
Medicine ·doi:10.1097/md.0000000000015466

We aimed to investigate the feasibility of robotic adenomyomectomy and compared surgical outcomes between laparoscopic and robotic approaches for adenomyomectomy.We retrospectively reviewed the data of women who were diagnosed with adenomyo…

observational 2019
·doi:10.60692/v9r87-9ce55

Dienogest has been shown to substantially improve endometriosis-associated symptoms such as debilitating chronic pelvic pain, and in turn, health-related quality of life (HRQoL). To date, there is no data on patient-reported outcomes reflec…

observational 2019
·doi:10.60692/41gzg-zzt23

Dienogest has been shown to substantially improve endometriosis-associated symptoms such as debilitating chronic pelvic pain, and in turn, health-related quality of life (HRQoL). To date, there is no data on patient-reported outcomes reflec…

other 2019
BMC women's health ·doi:10.1186/s12905-019-0758-6

BACKGROUND: Dienogest has been shown to substantially improve endometriosis-associated symptoms such as debilitating chronic pelvic pain, and in turn, health-related quality of life (HRQoL). To date, there is no data on patient-reported out…

observational 2017
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology ·doi:10.1080/01443615.2017.1312313

This study aimed to determine whether the menstrual cycle affects operative bleeding and postoperative ovarian reserve in patients undergoing laparoscopic ovarian cystectomy. A total of 155 patients who had undergone laparoscopic ovarian cy…

observational 2016
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115625841

Endometriosis is a major cause of disability in women, and 40% to 50% of patients experience disease recurrence by 5 years after surgery. This multicenter retrospective cohort study (N = 588) determined the rate and risk factors for recurre…

observational 2016
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2016.03.017

OBJECTIVE: To evaluate the cumulative recurrence rates of ovarian endometrioma among patients using a levonorgestrel-releasing intrauterine system (LNG-IUS) after conservative laparoscopic surgery. METHODS: A retrospective review was condu…